Your browser doesn't support javascript.
The International Sexual Health And REproductive Health during COVID-19 (I-SHARE) Study: A Multicountry Analysis of Adults from 30 Countries Prior to and During the Initial Coronavirus Disease 2019 Wave.
Toller Erausquin, Jennifer; Tan, Rayner K J; Uhlich, Maximiliane; Francis, Joel M; Kumar, Navin; Campbell, Linda; Zhang, Wei Hong; Hlatshwako, Takhona G; Kosana, Priya; Shah, Sonam; Brenner, Erica M; Remmerie, Lore; Mussa, Aamirah; Klapilova, Katerina; Mark, Kristen; Perotta, Gabriela; Gabster, Amanda; Wouters, Edwin; Burns, Sharyn; Hendriks, Jacqueline; Hensel, Devon J; Shamu, Simukai; Marie Strizzi, Jenna; Esho, Tammary; Morroni, Chelsea; Eleuteri, Stefano; Sahril, Norhafiza; Yun Low, Wah; Plasilova, Leona; Lazdane, Gunta; Marks, Michael; Olumide, Adesola; Abdelhamed, Amr; López Gómez, Alejandra; Michielsen, Kristien; Moreau, Caroline; Tucker, Joseph D.
  • Toller Erausquin J; Department of Public Health Education, University of North Carolina-Greensboro, Greensboro, North Carolina, USA.
  • Tan RKJ; Dermatology Hospital of Southern Medical University, Guangzhou, China.
  • Uhlich M; University of North Carolina Project-China, Guangzhou, China.
  • Francis JM; Saw Swee Hock School of Public Health, National University of Singapore, Singapore.
  • Kumar N; Department of Psychology, Western University, London, Ontario, Canada.
  • Campbell L; Department of Family Medicine, School of Clinical Medicine, University of Witwatersrand, Johannesburg, South Africa.
  • Zhang WH; Department of Sociology, Yale University, New Haven, Connecticut, USA.
  • Hlatshwako TG; Center for Population, Family, and Health, University of Antwerp, Antwerp, Belgium.
  • Kosana P; Department of Public Health and Primary Care, Faculty of Medicine and Health Sciences, University of Ghent, Ghent, Belgium.
  • Shah S; Department of Public Health and Primary Care, Faculty of Medicine and Health Sciences, University of Ghent, Ghent, Belgium.
  • Brenner EM; School of Public Health, Université Libre de Bruxelles, Brussels, Belgium.
  • Remmerie L; Institute of Global Health and Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
  • Mussa A; Institute of Global Health and Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
  • Klapilova K; Institute of Global Health and Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
  • Mark K; Institute of Global Health and Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
  • Perotta G; Department of Public Health and Primary Care, Faculty of Medicine and Health Sciences, University of Ghent, Ghent, Belgium.
  • Gabster A; Botswana Sexual and Reproductive Health Initiative, Botswana Harvard AIDS Institute Partnership, Gaborone, Botswana.
  • Wouters E; Faculty of Humanities, Charles University, Prague, Czech Republic.
  • Burns S; National Institute of Mental Health, Klecany, Czech Republic.
  • Hendriks J; Department of Family Medicine and Community Health, University of Minnesota Medical School, Minneapolis, Minnesota, USA.
  • Hensel DJ; Faculty of Psychology, University of Buenos Aires, Buenos Aires, Argentina.
  • Shamu S; Gorgas Memorial Institute for Health Studies, Panama City, Panama.
  • Marie Strizzi J; Clinical Research Department, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, United Kingdom.
  • Esho T; Center for Population, Family, and Health, University of Antwerp, Antwerp, Belgium.
  • Morroni C; Collaboration for Evidence, Research and Impact in Public Health, School of Population Health, Curtin University, Perth, Australia.
  • Eleuteri S; Collaboration for Evidence, Research and Impact in Public Health, School of Population Health, Curtin University, Perth, Australia.
  • Sahril N; Department of Pediatrics, Indiana University School of Medicine, Indianapolis, Indiana, USA.
  • Yun Low W; Department of Sociology, Indiana University-Purdue University Indianapolis, Indianapolis, Indiana, USA.
  • Plasilova L; Health Systems Strengthening, Foundation for Professional Development, Pretoria, South Africa.
  • Lazdane G; School of Public Health, University of Witwatersrand, Johannesburg, South Africa.
  • Marks M; Department of Public Health, University of Copenhagen, Copenhagen, Denmark.
  • Olumide A; End FGM/C Centre of Excellence, Amref Health Africa, Nairobi, Kenya.
  • Abdelhamed A; Botswana Sexual and Reproductive Health Initiative, Botswana Harvard AIDS Institute Partnership, Gaborone, Botswana.
  • López Gómez A; MRC Centre for Reproductive Health, University of Edinburgh, Edinburgh, United Kingdom.
  • Michielsen K; Department of Psychology, Sapienzo University, Rome, Italy.
  • Moreau C; Ministry of Health Malaysia, Putrajaya, Malaysia.
  • Tucker JD; Asia-Europe Institute, Universiti Malaya, Kuala Lumpur, Malaysia.
Clin Infect Dis ; 75(1): e991-e999, 2022 Aug 24.
Article in English | MEDLINE | ID: covidwho-1806302
ABSTRACT

BACKGROUND:

There is limited evidence to date about changes to sexual and reproductive health (SRH) during the initial wave of coronavirus disease 2019 (COVID-19). To address this gap, our team organized a multicountry, cross-sectional online survey as part of a global consortium.

METHODS:

Consortium research teams conducted online surveys in 30 countries. Sampling methods included convenience, online panels, and population-representative. Primary outcomes included sexual behaviors, partner violence, and SRH service use, and we compared 3 months prior to and during policy measures to mitigate COVID-19. We conducted meta-analyses for primary outcomes and graded the certainty of the evidence.

RESULTS:

Among 4546 respondents with casual partners, condom use stayed the same for 3374 (74.4%), and 640 (14.1%) reported a decline. Fewer respondents reported physical or sexual partner violence during COVID-19 measures (1063 of 15 144, 7.0%) compared to before COVID-19 measures (1469 of 15 887, 9.3%). COVID-19 measures impeded access to condoms (933 of 10 790, 8.7%), contraceptives (610 of 8175, 7.5%), and human immunodeficiency virus/sexually transmitted infection (HIV/STI) testing (750 of 1965, 30.7%). Pooled estimates from meta-analysis indicate that during COVID-19 measures, 32.3% (95% confidence interval [CI], 23.9%-42.1%) of people needing HIV/STI testing had hindered access, 4.4% (95% CI, 3.4%-5.4%) experienced partner violence, and 5.8% (95% CI, 5.4%-8.2%) decreased casual partner condom use (moderate certainty of evidence for each outcome). Meta-analysis findings were robust in sensitivity analyses that examined country income level, sample size, and sampling strategy.

CONCLUSIONS:

Open science methods are feasible to organize research studies as part of emergency responses. The initial COVID-19 wave impacted SRH behaviors and access to services across diverse global settings.
Subject(s)
Keywords
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Sexually Transmitted Diseases / HIV Infections / Sexual Health / COVID-19 Type of study: Observational study / Prognostic study / Randomized controlled trials / Reviews Limits: Adult / Humans Language: English Journal: Clin Infect Dis Journal subject: Communicable Diseases Year: 2022 Document Type: Article Affiliation country: Cid

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Sexually Transmitted Diseases / HIV Infections / Sexual Health / COVID-19 Type of study: Observational study / Prognostic study / Randomized controlled trials / Reviews Limits: Adult / Humans Language: English Journal: Clin Infect Dis Journal subject: Communicable Diseases Year: 2022 Document Type: Article Affiliation country: Cid